Developing a healthy future

Latest COVID-19 News

Australian startups push for bigger role in vaccine-making

August 17, 2020

By Emma Koehn August 9, 2020 — 2.54pm | The Sydney Morning Herald   An Australian startup racing to develop a successful…

Read More

COVID19 Pandemic Products – Hand Sanitisers and Disposable Masks

July 13, 2020

“Everyone who prepares is one less person who panics in a pandemic” As Sypharma continues to closely monitor the CoVID-19…

Read More

Sypharma partners with The University of Queensland for the manufacture of their CoVID-19 Vaccine Product

July 13, 2020

Around the world, pharmaceutical manufacturers and researchers’ objectives remain the same. To protect the safety of our community and to…

Read More

Sypharma is an Australian speciality contract manufacturing group, motivated by a commitment to creating healthier futures.

Since 2005 we’ve developed and manufactured therapeutic goods, veterinary products, and speciality consumer products.

We’re a trusted partner and provider of biotechnology healthcare products in Australia and we partner to contract manufacture products for local and international markets.

Our Capabilities

At Sypharma we specialise in contract manufacturing products for early clinical to Phase I, II, and III clinical trials, and have a range of multipurpose cleanrooms for the manufacture of oral or topical drugs and devices.

Equipped with modern, comprehensive and specialised manufacturing equipment services, our expertise and experience are available to clients seeking the manufacture and packaging of therapeutic goods, veterinary products and consumer items. Our licenses include accreditation from the FDA, TGA, ISO13485 and USFDA.

Our Products

Sypharma manufactures products from R&D right through to commercial volumes, both large and small volume parenteral and has a veterinary manufacturing suite which is distributed under the brands Sykes, Rudduck, Potties, Vetex, and Rapidvite.

Innovation at Sypharma

In addition to contract manufacturing development, we work with partners to innovate and develop new technologies.

Sypharma has a proven track record of successful drug development within the national and international arena and the expertise to manage end-to-end development within a world-class Australian facility.